GOED launches clinical study database on EPA and DHA omega-3s
More than 50 independent research assistants reviewed over 40,000 studies on omega-3s to create a comprehensive, searchable tool detailing nearly 4,000 human clinical trials.
Photo © iStockphoto.com/nicolas_
GOED (Global Organization for EPA and DHA Omega-3s) has launched its Clinical Study Database. The databased is a specialized search tool focused on scientific literature surrounding EPA and DHA omega-3s. According to GOED, more than 50 independent research assistants reviewed over 40,000 studies on omega-3s to create a comprehensive, searchable tool detailing nearly 4,000 human clinical trials. The database can be filtered by population, intervention, dosage, study characteristics, and more.
“With this tool, we’re helping researchers and scientists save countless hours of PubMed searches and journal article reading,” said Kaitlin Roke, PhD, director of scientific communication and outreach for GOED. “We see companies using this to understand the body of evidence supporting their omega-3 products, help substantiate claims on marketing materials and inform product development or new research into emerging scientific areas.”
The database can be accessed through subscription on an annual or quarterly basis, with an option to also commission an individual concierge project for a specific need. A virtual demonstration of the database can be viewed here.
Magnesium L-threonate, Magtein, earns novel food authorization in the European Union
December 19th 2024According to the announcement, the authorization is also exclusive to AIDP and its partner company and licensee, ThreoTech, meaning that they are the only parties that can market magnesium L-threonate in the EU for a period of five years.
